Clinical Trial Update: Performance of AclarusDx® a Blood-Based Transcriptomic Test for AD, in French Patients Newly Referred to a Memory Center

View source ↗

Summary

A completed clinical trial evaluates how well AclarusDx, a blood-based transcriptomic test for Alzheimer's disease, performs in French patients newly referred t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• AclarusDx

Snippet

Sponsor: Diaxonhit | Conditions: Cognitive Impairment, Memory Complaint | Status: COMPLETED